Mazor Robotics (NSDQ:MZOR) said today it won FDA clearance for its Mazor X Align spinal surgical planning software, with plans to launch in early May.

The Mazor X Align software is designed to assist surgeons in planning for spinal deformity correction and spinal alignment procedures with the Mazor X Surgical Assurance platform, the Israel-based company said.

“Mazor X Align is the product of Mazor’s development program and represents our innovative pipeline and visionary team experience. We are dedicated to pushing the envelope bringing to the market advanced products and applications in order to benefit an increasing number of patients suffering from difficult conditions and supporting the medical professionals serving them,” CEO Ori Hadomi said in a press release.

The Align software is the most recent addition to the company’s Mazor X pre-operative analytics software suite designed to create patient-specific, 3D spinal alignment plans. The company said

Mazor Robotics said that the initial release in May will be followed by a larger release during the 2nd half of 2017.